Table 1.
Edeposit (V) | n | ECSA (μm2) | ρ | ΔE1/2 (mV) | ΔE1/4 (mV) | ΔE3/4 (mV) |
---|---|---|---|---|---|---|
bare CFE | 14 | 277 ± 11b | 219 ± 9b | |||
−0.3 | 10 | 55.0 ± 14.1 | 1.98 ± 0.51 | −80 ± 18 | 193 ± 10** | 155 ± 14** |
−0.4 | 14 | 94.4 ± 14.8 | 3.41 ± 0.53 | −74 ± 15 | 207 ± 6** | 132 ± 17** |
−0.5 | 12 | 101.1 ± 23.0 | 3.65 ± 0.83 | −105 ± 19 | 175 ± 14** | 147 ± 20* |
−0.6 | 10 | 133.0 ± 28.9 | 4.80 ± 1.04 | −79 ± 27 | 170 ± 12** | 144 ± 12 |
ECSA and ρ are from H2SO4 CVs, and ΔE1/2, ΔE1/4, ΔE3/4 are from dopamine CVs. Significance of kinetic enhancement was assessed using paired Mann-Whitney test.
p < 0.01,
p < 0.05.
Bare CFE kinetic data corresponds to unmodified electrodes from the −0.4 V group.